Arrowhead Research Corp (NASDAQ:ARWR)

During the Trading Day
6.80 +0.23 / +3.50%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.79 -0.01 / -0.15%
Volume: 53.2K
Health Technology

Company Description

Arrowhead Research Corp. is a biopharmaceutical company developing targeted RNAi therapeutics. It is leveraging its proprietary drug delivery technologies to develop drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Its pipeline includes clinical programs in chronic hepatitis B virus and partner based programs in obesity and oncology. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Contact Information

Arrowhead Research Corp.
225 South Lake Avenue
Pasadena California 91101-3009
P:(626) 304-3400
Investor Relations:



Other institutional43.16%
Mutual fund holders34.50%
Individual stakeholders1.01%

Top Executives

Christopher R. AnzalonePresident, Chief Executive Officer & Director
Bruce D. GivenChief Operating Officer
Kenneth Allen MyszkowskiChief Financial Officer
David LewisChief Scientific Officer
Jane DavidsonSecretary & Vice President-Administration

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.